U.S. Stock News

If you are wondering whether TriCo Bancshares is fairly priced or offering value at its recent levels, this article will walk you through what the numbers actually say about the stock. The share price last closed at US$49.77, with returns of a 0.9% decline over 7 days, 1.4% over 30 days, 5.6% year to date, 18.6% over 1 year and 26.7% over 5 years. This naturally raises questions about how much is already reflected in the price and how much risk is being priced in. Recent coverage of TriCo...

Urban Outfitters FY 2026 results: steady revenue and earnings backdrop Urban Outfitters (URBN) has just wrapped up FY 2026 with fourth quarter revenue of US$1.8 billion, basic EPS of US$1.07 and net income of US$96.3 million, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$1.53 billion in Q3 FY 2026 to US$1.8 billion in Q4, while basic EPS shifted from US$1.30 to US$1.07 over the same stretch, and trailing twelve month EPS...

If you are wondering whether Carter's current share price offers value or potential risk, starting with the recent share performance and valuation checks can give you a clearer picture. Carter's shares last closed at US$42.07, with returns of 0.1% over 7 days, 20.7% over 30 days, 26.7% year to date, 4.4% over 1 year, along with 36.1% and 38.8% declines over 3 and 5 years respectively. Recent news coverage has focused on Carter's positioning in the childrenswear market and investor interest...

SkyWater Technology (SKYT) Posts Mixed FY 2025 Finish With Big Q3 EPS Spike and Q4 Loss SkyWater Technology (SKYT) closed out FY 2025 with Q4 revenue of US$171.0 million and a basic EPS loss of US$0.16, following a Q3 that featured US$150.7 million in revenue and a sharp basic EPS jump to US$2.98 on net income of US$144.0 million. Over recent periods the company has seen quarterly revenue move from US$75.5 million in Q4 2024 to US$61.3 million in Q1 2025, US$59.1 million in Q2 2025, and then...

ON24 (ONTF) has wrapped up FY 2025 with fourth quarter revenue of US$34.6 million and a basic EPS loss of US$0.15, as net income excluding extra items came in at a loss of US$6.5 million. Over recent quarters the company has seen revenue hold in a tight band between US$34.6 million and US$36.7 million, while quarterly basic EPS losses have ranged from US$0.15 to US$0.27 over the periods shown. This gives investors a clearer view of how top line scale lines up against persistent losses. With...

ADT (NYSE:ADT) has acquired Origin AI, a company focused on camera free AI presence sensing technology. The deal includes Origin AI's patent portfolio and will be integrated into ADT's smart home security platform. ADT has also signed a long term commercial agreement with Verisure to bring this AI sensing technology to Europe and Latin America. For investors watching NYSE:ADT at a share price of $8.11, this move signals a push to differentiate its smart home offering with AI driven presence...

EPR Properties (EPR) has wrapped up FY 2025 with fourth quarter revenue of US$182.9 million and basic EPS of US$0.80, while trailing twelve month revenue sits at US$718.4 million and EPS at US$3.30. Over the past few reported periods, revenue has ranged between US$172.4 million and US$185.1 million per quarter, with basic EPS moving between US$0.79 and US$0.91 across 2025, giving investors a clearer sense of how the income stream is tracking into the current run rate. With trailing net...

Rackspace Technology FY 2025 Earnings: Revenue Holds Steady As Losses Narrow Rackspace Technology (RXT) just closed out FY 2025 with Q4 revenue of US$682.8 million and a basic EPS loss of US$0.13, alongside trailing 12 month revenue of US$2.69 billion and a full year net loss of US$225.8 million. The company has seen quarterly revenue move from US$665.4 million in Q1 2025 to US$682.8 million in Q4 2025, while quarterly EPS losses over the same period ranged from US$0.31 to US$0.13. This gives...

Hormel Foods (HRL) opened fiscal Q1 2026 with revenue of about US$3.0 billion and basic EPS of US$0.33, setting a clear snapshot of where the business stands as earnings season gets underway. The company has seen quarterly revenue move in a tight band around US$3.0 billion over the past year, while basic EPS has ranged from a loss of roughly US$0.10 in Q4 2025 to US$0.40 in Q4 2024. This gives investors a mixed but data rich backdrop for judging this quarter. With trailing net profit margin...

TWFG (TWFG) has just posted its FY 2025 numbers, with Q4 revenue at US$68.8 million and basic EPS of US$0.18. This caps off a trailing twelve month profile that includes revenue of US$247.1 million and basic EPS of US$0.51 alongside reported earnings growth of 179.5% over the past year. The company has seen revenue rise from US$49.5 million in Q4 2024 to US$68.8 million in Q4 2025, while quarterly EPS has moved from US$0.11 to US$0.18. This sets the backdrop for analyst forecasts that point...

Snowflake (SNOW) just closed out FY 2026 with fourth quarter revenue of US$1.3 billion and a basic EPS loss of US$0.90, alongside net income excluding extra items of a US$309.6 million loss. Over recent periods the company has seen quarterly revenue move from US$986.8 million in Q4 FY 2025 through US$942.1 million and US$1.0 billion to US$1.1 billion and US$1.2 billion before reaching US$1.3 billion, while basic EPS losses ranged between about US$0.86 and US$1.29 per share. The headline story...

Ingevity (NGVT) posts mixed FY 2025 finish as earnings swing Ingevity (NGVT) just closed FY 2025 with Q4 revenue of US$255.1 million and basic EPS of a US$2.21 loss, a sharp contrast to Q4 FY 2024 when revenue was US$298.8 million and EPS was US$0.46. Over recent quarters the company has seen revenue move from US$340.1 million in Q1 2024 to US$284 million in Q1 2025, and from US$333.8 million in Q3 2024 to US$333.1 million in Q3 2025. Quarterly EPS has ranged from a US$1.54 loss in Q1 2024 to...

Koppers Holdings (KOP) has wrapped up FY 2025 with fourth quarter revenue of US$432.7 million and basic EPS of US$1.52, while trailing twelve month figures show revenue of about US$1.9 billion and EPS of US$2.82. Over recent periods, quarterly revenue has ranged from US$456.5 million to US$504.8 million in FY 2025, with basic EPS moving from a loss of US$0.68 in Q1 2025 to US$1.21 in Q3 2025 and US$1.12 in Q3 2024. This sets up a story where modest earnings growth, a 3% net margin and a low...

Latest FY 2025 Earnings Snapshot Catalyst Pharmaceuticals (CPRX) just wrapped up FY 2025 with Q4 revenue of US$152.6 million and basic EPS of US$0.43, alongside net income of US$52.7 million, putting concrete numbers around its latest earnings season update. The company has seen quarterly revenue move from US$141.8 million in Q4 2024 to US$152.6 million in Q4 2025, while basic EPS shifted from US$0.47 to about US$0.43 over the same periods. Trailing twelve month EPS stands at US$1.75 and...

Ardagh Metal Packaging (NYSE:AMBP) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$16m loss. Over recent periods the company has seen revenue move from US$1.2b in Q4 2024 to US$1.3b in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of roughly US$0.04, while trailing twelve month net income excluding extra items sits at US$11m on US$5.5b of revenue. With the company now...

Enovix (ENVX) closed FY 2025 with Q4 revenue of US$11.3 million, a basic EPS loss of US$0.16 and a net income loss of US$35.0 million. Over recent quarters the company has seen revenue move from US$9.7 million in Q4 2024 to US$11.3 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.20 to a loss of US$0.16. This sets the stage for investors to focus on how quickly margins might tighten or widen from here. See our full analysis for Enovix. With the headline numbers on the...

Inhibikase Therapeutics (IKT) has moved into focus after fresh FDA designations and progress in its Phase 2a trial for IkT-148009 targeting Parkinson’s disease, even as ongoing financial instability remains part of the picture. See our latest analysis for Inhibikase Therapeutics. The recent FDA designations and Phase 2a progress appear to be feeding into momentum, with a 7 day share price return of 20.11% and a 90 day share price return of 37.50%, even though the 1 year total shareholder...

Eos Energy Enterprises (EOSE) just released its FY 2025 numbers with Q4 revenue at US$58.0 million and basic EPS of US$4.19, while the latest trailing twelve month figures show revenue of US$114.2 million and a basic EPS loss of US$0.75. The company has seen quarterly revenue move from US$7.3 million and a basic EPS loss of US$2.20 in Q4 2024 to US$58.0 million and basic EPS of US$4.19 in Q4 2025, with trailing twelve month net income at a US$194.5 million loss. These figures are shaping how...

If you are wondering whether Victoria's Secret shares still offer value after a strong run, the key is to look past the headlines and focus on what the current price really implies. The stock most recently closed at US$65.75, with returns of 7.2% over 7 days, 17.6% over 30 days, 23.2% year to date, 144.7% over 1 year and 74.2% over 3 years. Recent attention around Victoria's Secret has centered on its position in the US retail space and how investors view its brand and store footprint. This...

Donaldson (DCI) just posted its Q2 2026 scorecard, with revenue of US$896.3 million and basic EPS of US$0.80, set against trailing twelve month revenue of US$3.8 billion and EPS of US$3.24 that frame the latest quarter in a broader run of results. Over recent quarters, revenue has moved between US$870 million and US$980.7 million while quarterly EPS has ranged from US$0.49 to just under US$0.99, giving investors a clearer view of how the current print sits within the recent earnings pattern...

Glacier Bancorp (GBCI) just closed FY 2025 with fourth quarter revenue of US$266.9 million and basic EPS of US$0.49, alongside full year trailing twelve month revenue of US$952.7 million and EPS of US$2.00 that reflected 25.7% earnings growth over the past year. Over recent periods, revenue has moved from US$802.5 million to US$952.7 million on a trailing twelve month basis, while EPS has gone from US$1.68 to US$2.00. This sets up a story that now centers on how sustainable those margins and...

Fate Therapeutics (FATE) closed out FY 2025 with Q4 revenue of US$1.4 million and a basic EPS loss of US$0.27, alongside a net loss of US$32.4 million. On a trailing 12 month basis, the company recorded revenue of US$6.6 million and a basic EPS loss of US$1.15 tied to a net loss of US$136.3 million. Over recent quarters, the business has seen quarterly revenue range between US$1.4 million and US$1.9 million and quarterly basic EPS losses move between US$0.27 and US$0.32. This keeps the focus...

Maravai LifeSciences Holdings (MRVI) has wrapped up FY 2025 with fourth quarter revenue of US$49.9 million and a basic EPS loss of US$0.25, set against a trailing twelve month loss of US$0.91 per share on revenue of US$185.7 million. Over recent quarters the company has seen revenue move from US$56.4 million in Q4 2024 to US$41.6 million in Q3 2025 and then to US$49.9 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.19 in Q4 2024 to losses between US$0.18 and US$0.27...

If you are wondering whether Black Hills at around US$73.83 is offering fair value or a potential mispricing, you are not alone in asking that question right now. The stock has returned 1.0% over the last 7 days, 0.3% over 30 days, 6.0% year to date and 27.5% over 1 year, with a 36.7% return over 3 years and 50.7% over 5 years, which gives useful context before comparing price with underlying value. Recent news around Black Hills has largely focused on its position in the regulated utilities...